Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Izopet

Showing results (11-20 of 498) with videos related to

Pageof 50
Sort By:
Nephrologie & Therapeutique|February 15, 2008
[Prevalence and incidence of hepatitis C virus in hemodialysis: diagnosis and prevention]Nassim Kamar, Jacques Izopet, Lionel Rostaing
La Revue Du Praticien|March 15, 2019
[Hepatitis E virus infection]Olivier Marion, Jacques Izopet, Nassim Kamar
The New England Journal of Medicine|June 19, 2014
Ribavirin for chronic hepatitis E virus infectionNassim Kamar, Vincent Mallet, Jacques Izopet
Journal of Nephropathology|January 30, 2014
Hepatitis C virus infection in nephrology patientsLionel Rostaing, Jacques Izopet, Nassim Kamar
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 24, 2022
Omicron breakthrough infection in a kidney-transplant patient given pre-exposition casirivimab and imdevimab monoclonal antibodiesNassim Kamar, Anna Gouin, Jacques Izopet
Viruses|October 26, 2021
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral TreatmentMarion Migueres, Sébastien Lhomme, Jacques Izopet
Transfusion|August 19, 2014
Safety measures to prevent hepatitis E virus transmission by blood transfusionSyria Laperche, Jacques Izopet, Jean-Jacques Lefrère
Future Microbiology|December 18, 2014
Hepatitis E in developed countries: current status and future perspectivesHarry R Dalton, Nassim Kamar, Jacques Izopet
Expert Opinion on Investigational Drugs|July 16, 2010
New NS5B polymerase inhibitors for hepatitis CFlorence Legrand-Abravanel, Florence Nicot, Jacques Izopet
Journal of Clinical and Experimental Hepatology|March 11, 2015
Chronic hepatitis e virus infection and treatmentNassim Kamar, Jacques Izopet, Harry R Dalton
Pageof 50

Showing results (11-20 of 498) with videos related to

Sort By:
Pageof 50
Nephrologie & Therapeutique|February 15, 2008
[Prevalence and incidence of hepatitis C virus in hemodialysis: diagnosis and prevention]Nassim Kamar, Jacques Izopet, Lionel Rostaing
La Revue Du Praticien|March 15, 2019
[Hepatitis E virus infection]Olivier Marion, Jacques Izopet, Nassim Kamar
The New England Journal of Medicine|June 19, 2014
Ribavirin for chronic hepatitis E virus infectionNassim Kamar, Vincent Mallet, Jacques Izopet
Journal of Nephropathology|January 30, 2014
Hepatitis C virus infection in nephrology patientsLionel Rostaing, Jacques Izopet, Nassim Kamar
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 24, 2022
Omicron breakthrough infection in a kidney-transplant patient given pre-exposition casirivimab and imdevimab monoclonal antibodiesNassim Kamar, Anna Gouin, Jacques Izopet
Viruses|October 26, 2021
Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral TreatmentMarion Migueres, Sébastien Lhomme, Jacques Izopet
Transfusion|August 19, 2014
Safety measures to prevent hepatitis E virus transmission by blood transfusionSyria Laperche, Jacques Izopet, Jean-Jacques Lefrère
Future Microbiology|December 18, 2014
Hepatitis E in developed countries: current status and future perspectivesHarry R Dalton, Nassim Kamar, Jacques Izopet
Expert Opinion on Investigational Drugs|July 16, 2010
New NS5B polymerase inhibitors for hepatitis CFlorence Legrand-Abravanel, Florence Nicot, Jacques Izopet
Journal of Clinical and Experimental Hepatology|March 11, 2015
Chronic hepatitis e virus infection and treatmentNassim Kamar, Jacques Izopet, Harry R Dalton
Pageof 50